BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19010978)

  • 1. Mast cell chymase contributes to the antibody response and the severity of autoimmune arthritis.
    Magnusson SE; Pejler G; Kleinau S; Abrink M
    FASEB J; 2009 Mar; 23(3):875-82. PubMed ID: 19010978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal-associated invariant T cells promote inflammation and exacerbate disease in murine models of arthritis.
    Chiba A; Tajima R; Tomi C; Miyazaki Y; Yamamura T; Miyake S
    Arthritis Rheum; 2012 Jan; 64(1):153-61. PubMed ID: 21904999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Candida albicans cell wall glucan as adjuvant for induction of autoimmune arthritis in mice.
    Hida S; Miura NN; Adachi Y; Ohno N
    J Autoimmun; 2005 Sep; 25(2):93-101. PubMed ID: 16242302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High doses of interleukin-12 inhibit the development of joint disease in DBA/1 mice immunized with type II collagen in complete Freund's adjuvant.
    Hess H; Gately MK; Rüde E; Schmitt E; Szeliga J; Germann T
    Eur J Immunol; 1996 Jan; 26(1):187-91. PubMed ID: 8566065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of IL-10-producing CD4+CD25+ T cells in animal model of collagen-induced arthritis by oral administration of type II collagen.
    Min SY; Hwang SY; Park KS; Lee JS; Lee KE; Kim KW; Jung YO; Koh HJ; Do JH; Kim H; Kim HY
    Arthritis Res Ther; 2004; 6(3):R213-9. PubMed ID: 15142267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of Th1-mediated pathology in experimental arthritis by stimulation of the Th2 arm of the immune response.
    Mauri C; Feldmann M; Williams RO
    Arthritis Rheum; 2003 Mar; 48(3):839-45. PubMed ID: 12632440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
    Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM
    Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mouse mast cell-restricted tetramer-forming tryptases mouse mast cell protease 6 and mouse mast cell protease 7 are critical mediators in inflammatory arthritis.
    McNeil HP; Shin K; Campbell IK; Wicks IP; Adachi R; Lee DM; Stevens RL
    Arthritis Rheum; 2008 Aug; 58(8):2338-46. PubMed ID: 18668540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent adjuvant effect by anti-CD40 in collagen-induced arthritis. Enhanced disease is accompanied by increased production of collagen type-II reactive IgG2a and IFN-gamma.
    Tellander AC; Michaëlsson E; Brunmark C; Andersson M
    J Autoimmun; 2000 Jun; 14(4):295-302. PubMed ID: 10882055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells.
    Nandakumar KS; Bäcklund J; Vestberg M; Holmdahl R
    Arthritis Res Ther; 2004; 6(6):R544-50. PubMed ID: 15535832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unmethylated oligo-DNA containing CpG motifs aggravates collagen-induced arthritis in mice.
    Miyata M; Kobayashi H; Sasajima T; Sato Y; Kasukawa R
    Arthritis Rheum; 2000 Nov; 43(11):2578-82. PubMed ID: 11083283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Achievement of a synergistic adjuvant effect on arthritis induction by activation of innate immunity and forcing the immune response toward the Th1 phenotype.
    Hanyecz A; Berlo SE; Szántó S; Broeren CP; Mikecz K; Glant TT
    Arthritis Rheum; 2004 May; 50(5):1665-76. PubMed ID: 15146438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The involvement of V(alpha)14 natural killer T cells in the pathogenesis of arthritis in murine models.
    Chiba A; Kaieda S; Oki S; Yamamura T; Miyake S
    Arthritis Rheum; 2005 Jun; 52(6):1941-8. PubMed ID: 15934073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arthritis in mice that are deficient in interleukin-1 receptor antagonist is dependent on genetic background.
    Zhou F; He X; Iwakura Y; Horai R; Stuart JM
    Arthritis Rheum; 2005 Dec; 52(12):3731-8. PubMed ID: 16320323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressive oligonucleotides protect against collagen-induced arthritis in mice.
    Dong L; Ito S; Ishii KJ; Klinman DM
    Arthritis Rheum; 2004 May; 50(5):1686-9. PubMed ID: 15146440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of collagen-induced arthritis in mice by diesel exhaust particles.
    Yoshino S; Sagai M
    J Pharmacol Exp Ther; 1999 Aug; 290(2):524-9. PubMed ID: 10411558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence and role of anti-citrullinated protein antibodies in experimental arthritis models.
    Cantaert T; Teitsma C; Tak PP; Baeten D
    Arthritis Rheum; 2013 Apr; 65(4):939-48. PubMed ID: 23280233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen-induced, tolerogenic CD11c+,CD11b+ dendritic cells are abundant in Peyer's patches during the induction of oral tolerance to type II collagen and suppress experimental collagen-induced arthritis.
    Min SY; Park KS; Cho ML; Kang JW; Cho YG; Hwang SY; Park MJ; Yoon CH; Min JK; Lee SH; Park SH; Kim HY
    Arthritis Rheum; 2006 Mar; 54(3):887-98. PubMed ID: 16508971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The chymase, mouse mast cell protease 4, constitutes the major chymotrypsin-like activity in peritoneum and ear tissue. A role for mouse mast cell protease 4 in thrombin regulation and fibronectin turnover.
    Tchougounova E; Pejler G; Abrink M
    J Exp Med; 2003 Aug; 198(3):423-31. PubMed ID: 12900518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oleuropein aglycone, an olive oil compound, ameliorates development of arthritis caused by injection of collagen type II in mice.
    Impellizzeri D; Esposito E; Mazzon E; Paterniti I; Di Paola R; Morittu VM; Procopio A; Britti D; Cuzzocrea S
    J Pharmacol Exp Ther; 2011 Dec; 339(3):859-69. PubMed ID: 21880869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.